# Diagnostica Stago, Inc. (other, Parsippany, NJ): 6 new FDA device listings, incl. test, time, partial thromboplastin

**Score:** 65/100

| Field | Value |
|---|---|
| Establishment | Diagnostica Stago, Inc. |
| Role | Other |
| Establishment types | Complaint File Establishment per 21 CFR 820.198 |
| Location | Parsippany, NJ, US |
| New listings | 6 |
| Devices | Test, Time, Partial Thromboplastin; System, Fibrinogen Determination; Assay, Heparin; Test, Time, Prothrombin; System, Multipurpose For In Vitro Coagulation Studies; Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control |
| Product codes | GGW, KQJ, KFF, GJS, JPA, DAP |
| Device classes | Class II |
| Medical specialties | Hematology |
| Brand names | STA Satellite Max |
| First new listing | 2026-05-28 |
| Latest new listing | 2026-05-28 |
| FDA registration number | 2245451 |
| Registration expires | 2027-12-31 |

## Why this score
- Class II or III devices: QMS and regulatory demands.
- Several new listings at once.
- U.S. establishment.

Source: openFDA device registration and listing endpoint (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm). Last refreshed: 2026-11-04T21:52:36.524Z.
From the openFDA device registration and listing data, refreshed weekly. A listing shows a device an establishment says it makes or handles for the U.S. market; it is not FDA clearance or approval. Contact persons and street addresses are not stored. Verify in the FDA Establishment Registration and Device Listing database.